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ABSTRACT: Increased levels of oxidative stress are linked with many neurodegenerative diseases such 
as Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis. Therapeutic strategies 
aimed at identifying small molecules that are capable of conferring neuroprotection against oxidative 
stress are therefore of significant importance for developing effective treatments for these 
neurodegenerative diseases. A library of 76 compounds containing hydroxy flavones, methoxy flavones 
and their 4-thio analogues has been evaluated for neuroprotection against H2O2-induced oxidative 
stress. This study revealed the novel 7,8-dihydroxy 4-thioflavones as neuroprotective compounds, with 
compounds 14f and 18f showing highest neuroprotective effects at lower concentrations (0.3 μM). The 
neuroprotective activities were found to be mediated via activation of the anti-apoptotic cell survival 
proteins of the ERK1/2 and PI3K/Akt pathways. Structure activity relationship analysis revealed that the 
presence of the B-ring phenyl group is essential for the greater neuroprotective activities of the 
flavones studied herein. Additionally, replacing the 4-C=O moiety with a 4-C=S moiety enhances 
neuroprotection. These findings form the basis for further optimisation and in-depth drug 
development for treating various neurological disorders. 










Flavones, a subclass of flavonoids, are polyphenolic phytochemicals that have been well recognised for 
their diverse pharmacological activities such as antioxidant [1,2], anti-inflammatory [3,4], antimicrobial 
[5–7], cardioprotective [8,9], neuroprotective [10,11] and anticancer [12,13] activities. Due to their 
broad spectrum of pharmacological activities, the natural flavones have gained attention as potential 
medicinal chemistry scaffolds. In particular, several epidemiological in vitro and in vivo studies have 
highlighted the potential of flavonoids as neuroprotective agents. For example, natural flavonoids such 
as fisetin [14], luteolin, quercetin, myricetin and hesperetin [15–17] have been reported to protect 
neurons against oxidative damage. Further, several synthetic flavones and thioflavones [18] have 
limited neurodegeneration associated with a variety of neurological disorders, namely Alzheimer’s 




permeability of flavonoids have highlighted that the lipophilic polymethoxy flavonoids possess greater 
BBB permeability than the polar flavonoids; the permeability potency of the compounds also 
correlated with their lipophilicity (log P) [21,22]. With our interest in developing novel flavone 
derivatives as therapeutic agents, we had previously synthesised and characterised a library of 76 
hydroxy flavones, methoxy flavones and their 4-thio derivatives (Figure-1). As a result of the promising 
BBB permeability of methoxy flavones, as well as the absence of a systematic investigation of the 
effect of substitution of the 4-carbonyl (4-C=O) group by a 4-thiocarbonyl (4-C=S) group on the 
neuroprotective activities of flavones, we devised a programme of work to explore the structure-
activity relationships (SARs) of the library of 76 flavones presented herein. Thus hydroxy and methoxy 
flavones, along with their 4-thio derivatives, were evaluated for their neuroprotective effects against 
H2O2-induced oxidative stressed SH-SY5Y neuroblastoma cell line. Further, the molecular mechanisms 
of action of the most potent neuroprotective flavones were investigated. On the basis of these results, 










MATERIAL AND METHODS 
Chemicals: DPPH, Ascorbic acid, EDTA, ferrous chloride hexahydrate, ferrozine, hydrogen peroxide and 
sterile PBS with Ca2+ and Mg2+ were purchased from Sigma-Aldrich, UK. 
Cell line and Culture: SH-SY5Y (human neuroblastoma cell line) was purchased as a frozen stock from 
the European Collection of Cell Cultures (ECACC). SH-SY5Y cells were grown in DMEM:F-12 (1:1) [with 
sodium pyruvate] supplemented with 15% FBS and 1% NEAA in T-75 culture flasks (Greiner bio-one). 
All of the cell culture reagents were obtained from Lonza, UK. PathScan Intracellular Signaling array kit 
was purchased from Cell Signaling (Catalog number-7323). For the cell culture experiments, the stock 
solutions of the test compounds (10 mg/mL) were prepared in sterile DMSO and ethanol (1:1 v/v) and 
these stocks were then appropriately diluted with the complete culture medium and the ethanol and 
DMSO levels were maintained below 1% in the test concentrations. The IC50 values were calculated 
using Graphpad prism 6. 
H2O2-IC50 determination: SH-SY5Y cells were seeded at a density of 1.5 x 10
5 cells/mL into 96 well 
plates and incubated for 72 h. After 72 h, the medium was aspirated and the cells were washed twice 
with sterile PBS and then treated with a range of concentrations (0 to 1000 µM) of H2O2 in sterile PBS 
(with Ca2+ and Mg2+) for 1 h. After 1 h, H2O2 solution in the well was replaced with the warm medium 
and incubated for 17 h. After the 18 h exposure, the cell viability was determined using the MTT 
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assay[23]. The MTT assay involved the addition of 20 µL of MTT (5mg/mL) solution in PBS into each 
well followed by the incubation of the cells for 5 h. The purple formazan crystals formed were dissolved 
in 100 µL of DMSO and the plates were read at 570 nm using a SPECTRA max UV spectrometer (Bio-
Rad). The data represented are the mean of the three individual experiments. The cell viability of the 
control is considered to be 100%. 
Neuroprotective assay: SH-SY5Y cells were seeded at a density of 1.5 x 105 cells/mL into 96 well plates 
and incubated for 48 h. After 48 h, the cells were treated with these synthesised derivatives at a single 
dose of 3 µM or at a range of concentrations (0, 0.1, 1 and 3 µM) for 24 h. After 24 h of this treatment 
with the synthesised compounds, the medium was aspirated and the cells were washed twice with 
sterile PBS and then treated with 130 µM of H2O2 (IC50 concentration) in sterile PBS (with Ca
2+ and 
Mg2+) for 1 h. After 1 h, the H2O2 solution in the well was replaced with the warm medium and 
incubated for 17 h. After the 18 h exposure, the cell viability was determined using the MTT assay (as 
described earlier in the H2O2-IC50 determination section). The data represented are the mean of the 
three individual experiments. The cell viability of the control is considered to be 100%. 
Neurotoxicity assay: SH-SY5Y cells were seeded at a density of 1.5 x 105 cells/mL into 96 well plates 
and incubated for 48 h. After 48 h, the cells well treated with these synthesised derivatives at 3 µM and 
10 µM concentrations for 24 h. Following the 24 h exposure, the cell viability was assessed using MTT 
assay (as described previously). The cell viability of the control is considered to be 100%. 
DPPH Radical Scavenging Assay: The free radical scavenging activities of the samples were measured 
using the stable DPPH radical. The free radical scavenging activity of the samples was analyzed 
according to the method of Sulaiman et al [24]. Briefly, 0.3 mM solution of DPPH in ethanol was 
prepared. Test compounds (50 μL) (concentration-3 µM in ethanol) were added to 150 μL of the DPPH 
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solution in each well of a 96-well plate. For the blank, only 50 μL of ethanol was added to the DPPH 
solution. The plates were incubated in the dark for 30 min at 37 °C.  After 30 min, the decrease in 
absorbance was measured at 515 nm using a microplate reader (Spectramax 340PC). All tests were 
performed in triplicate. The capability to scavenge the DPPH radicals was calculated using the 
equation: (%) = [(Absorbance of control – Absorbance of sample)/ Absorbance of control] × 100. 
Ascorbic acid was used as a positive control. This protocol was validated by the determination of the 
IC50 of ascorbic acid (concentration range tested 1000 µM – 1 µM) and the IC50 value was found to be 
330  0.5 µM (Supplementary info, Figure-S2). All experiments were performed in triplicate. 
Metal chelating assay: The chelating activity for ferrous ions was assessed according to the method of 
Dinis et al [25].  50 μL of test compounds (concentration-3 µM in ethanol), and deionized water (130 
μL) were added to 96 well plates. 5 μL of ferrous chloride hexahydrate (2 mM) was added to each well 
and incubated for 5 min. 15 μL of ferrozine (5 mM) was added to initiate the ferrous-ferrozine complex 
reaction. After 10 min of incubation at room temp, the absorbance was measured at 562 nm using a 
microplate reader (Spectramax 340PC). The metal chelating ability of the test compounds was 
determined using the equation: (%) = [(Absorbance of control – Absorbance of sample)/ Absorbance of 
control] × 100. EDTA was used as a positive control. This protocol was validated by the determination of 
the IC50 of EDTA (concentration range tested 1000 µM – 1 µM) and the IC50 value was found to be 42  
0.8 µM (Supplementary info, Figure-S3). All experiments were performed in triplicate. 
PathScan sandwich immunoassay: The PathScan Intracellular Signalling array kit was used for the 
simultaneous detection of 18 significant and well-characterised cellular proteins and signalling nodes 
that were phosphorylated or cleaved at the specific residues.  
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Preparation of cell lysate: SH-SY5Y cells (2.5 x 105 cell/mL) were seeded into 24 well plates (2 mL/well) 
and incubated for 48 h. After 48 h, the cells were treated with the test compounds at 3 µM 
concentration for 24 h. After 24 h of this treatment, the medium was aspirated and the cells were 
washed twice with sterile PBS and then exposed to 130 µM of H2O2 (IC50 concentration) in sterile PBS 
(with Ca2+ and Mg2+) for 1 h. Following this H2O2 insult, the cells were washed with ice-cold 1X 
phosphate-buffered saline and lysed in 1X cell lysis buffer provided (phosphotase and protease 
inhibitors added).  These lysates were quantified using the BCA protein assay. 
Assay procedure: The array blocking buffer was added to each well of the glass slide provided and 
incubated for 15 min at room temperature. Subsequently, the cell lysate, diluted to 0.3 mg/mL in array 
diluents, was added to each well and incubated for 2 h at room temperature. Subsequent to washing, 
the detection antibody cocktail was added to each well and incubated for 1 h at room temperature. 
Horseradish peroxidase (HRP)-linked streptavidin was added to each well and incubated for 30 min at 
room temperature. The slide was then covered with LumiGLO/Peroxide reagent (Cell Signaling 
Technology) and exposed to film for 2–30 sec. The image was captured by a digital imaging system, 
ImageQuant LAS 4000 (GE Healthcare). 
BBB score prediction: BBB scores presented in this study were determined using the online, free 
access Blood-Brain Barrier Prediction Server- CBLigand, available from http://www.cbligand.org/BBB/ 
[Accessed 5th February 2016]. SVM algorithm and MACCS fingerprint were selected for the calculation. 
The predicted BBB scores for all 76 flavones presented in this study are provided in Table-S1, 
Supplementary Information.  




The flavone scaffolds presented in this study were designed according to medicinal chemistry 
strategies such as the bioisostere approach and Topliss scheme, and this resulted in three series of 
flavones; series-1 contained well-known flavones with different number of hydroxyls and their 
derivatives, series-2 contained bioisoteric analogues of the active flavone (determined from series-1) 
and series-3 contained derivatives with electron-withdrawing groups (EWGs) (Figure-1). These 
compounds were obtained using a conventional method involving a Baker-Venkataramann 
rearrangement [26,27] and the general synthetic routes that were adapted for access to these flavones 
have been previously reported by our laboratory [28]. The purities of these compounds were 
established by reverse phase HPLC and the purities were found to be >95% in all cases.  
The synthesised compounds (1c-f to 19c-f) were evaluated for their ability to protect neurons from 
H2O2-induced oxidative stress in an in vitro model using the SH-SY5Y human neuroblastoma cell line 
[29,30]. First, an appropriate concentration of H2O2 for inducing oxidative stress in SH-SY5Y cells was 
determined by exposing the SH-SY5Y cells to various concentrations of H2O2 (5-500 µM) for 18 h. From 
the cell viability assessment, using the MTT assay, it was found that H2O2 at 130 µM (IC50 value) 
induces a 50% reduction in the SH-SY5Y cell viability (Supplementary info, Figure-S1). Hence, this 
concentration (130 µM) was used for further experiments to induce oxidative stress in SH-SY5Y cells. 
In order to determine the protective effects of compounds 1c-f to 19c-f on H2O2-oxidative cell injury, 
SH-SY5Y cells were treated with each of these compounds at the physiologically relevant concentration 
of 3 µM concentration [31] for 24 h prior to exposure to H2O2 (18 h). The cell viability was determined 
by the MTT assay and the results are shown in Figure-2. Treatment with H2O2 at 130 µM exhibited an 
approximate 50% reduction of the cell viability in comparison to the control.  
Effect of number of hydroxyls present on the flavonoid scaffold: Among series-1, comprising of 
flavones with differing number of hydroxyls, the hydroxy flavones 1d, 1f, 4d, 4f and 5d (cell 
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viability>70%) showed significant protection of SH-SY5Y cells against H2O2 induced oxidative stress. 
Among the hydroxy flavones it was found that those bearing catecholic hydroxyl (o-hydroxy) 
substitutions either on ring-A or -B exerted significant neuroprotective effects, with the exception of 
3d and 3f. In contrast, flavones that lack these functionalities (for example 2d and 2f with C-5,7 
hydroxyl (m-hydroxy) groups) were found to be inactive (cell viability < 50%). This observation 
indicates that the presence of catecholic hydroxyl groups is necessary for the neuroprotective activity 
and this observation is in line with previous studies of natural flavones [32]. Comparison of the 
activities of 4d and 5d indicates that the presence of the C-3 hydroxyl group decreases the 
neuroprotective ability of flavonoids, however this observation is contradictory to a previous report 
that suggests that the hydroxy substitutions in the A-ring (C-5,7) and at position C-3 (C-ring) of the 
flavones are necessary to afford neuronal cell protection [33]. Also, no definite correlations were 
observed between the number of hydroxyls and neuroprotective ability. Among these derivatives 
(Series-1), the hydroxy 4-thioflavones were found to be less active than their corresponding hydroxy 
flavones. Further, the methoxy flavones (both 4-C=O and 4-C=S) were found to be inactive, which 
indicates that the presence of free hydroxyl groups is necessary for neuroprotective activity. In this 
series, compounds 1d and 4d (cell viability = 96.15 ± 4.02% and 98.37 ± 3.81%, for 1d and 4d 









Figure 2. Neuroprotective effects of (A) compounds 1c-f to 5c-f (B) compounds 6c-f to 11c-f and (C) compounds 12c-f to 
19c-f at 3 µM concentration against H2O2-induced oxidative stress in SH-SY5Y cells. Cells without treatment serve as 
control. Cell viability was measured by MTT assay. Statistical significance was estimated by one-way ANOVA followed by 
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(**p < 0.01, ***p < 0.001 and ****p < 0.0001). Colour coding: blue-hydroxy flavone (-OH, 4-C=O), red-hydroxy 4-
thioflavone (-OH, 4-C=S), purple-methoxy flavone (-OMe, 4-C=O) and green-methoxy 4-thioflavone (-OMe, 4-C=S).  
Effect of bioisosteric replacement: To further explore the structure-activity relationships, the series of 
synthesised bioisosteric analogues (compounds 6c-f to 11c-f) were screened at 3 µM concentration for 
their neuroprotective properties. As shown in Figure-2A, replacement of the B-ring phenyl group in 
compound-1d with a 2-thienyl moiety resulted in a decreased neuroprotective activity (cell viability = 
96.15 ± 4.02% vs 69.73 ± 4.81%, for 1d and 6d respectively), whereas replacement with the 2-furanyl 
and 3-pyridyl groups has resulted in a significant loss of neuroprotective activity (cell viability < 60%). 
As previously observed, the 5,7-regioisomeric analogues (both 4-C=O and 4-C=S) and the methoxy 
analogues (both 4-C=O and 4-C=S as well as 5,7-regiomers) were found to be inactive (cell viability < 
50%). These observations therefore suggest that bioisosteric replacement of the B-ring phenyl group is 
detrimental for the neuroprotective activities.  
Influence of electron-withdrawing groups: As part of the optimisation and systematic SAR evaluation, 
compounds 12c-f to 19c-f with electron-withdrawing substituents at the C-4’ position of the B-ring 
phenyl moiety were analysed for their neuroprotective activities at 3 µM concentrations. The 7,8-
hydroxy flavone and 4-thio flavone analogues 12d (cell viability = 88.81 ± 2.53%), 12f (cell viability = 
97.40 ± 4.30%), 14d (cell viability = 93.36 ± 1.47%), 14f (cell viability = 106.75 ± 1.22%), 16d (cell 
viability = 84.00 ± 3.60%), 16f (cell viability = 97.85 ± 2.58%), 18d (cell viability = 84.64 ± 1.69%), and 
18f (cell viability = 105.85 ± 3.72%) were found to be neuroprotective, whereas the 5,7-hydroxy and 
methoxy analogues exhibited poor neuroprotective activities (cell viability < 50%) (Figure-2C). 




Overall, among the three series of flavone analogues, compounds 1d, 4d, 12d, 12f, 14d, 14f, 16d, 16f, 
18d and 18f exhibited the highest neuroprotective effects at a single dose of 3 µM. Hence, these 
compounds were further evaluated at lower concentrations to determine their ability to exert 
neuronal protection against H2O2-induced oxidative stress. As shown in Figure-3, compounds 1d, 4d, 
12d, 12f, 14d, 16d, 16f and 18d exerted neuroprotective effects only at 3 µM and no significant 
protective effects were observed at lower concentrations. Interestingly, the novel compounds 14f and 
18f were found to be effective even at 0.3 µM concentration (cell viability >70%). 
Further, the toxicity of compounds 1d, 4d, 12d, 12f, 14d, 16d, 16f and 18d was also determined by 
exposing the SH-SY5Y cells to 3 µM and 10 µM doses of these compounds for 24 h. The cell viability 
assessment (using the MTT assay) revealed that these compounds were not toxic to SH-SY5Y cells at 
the concentrations tested except for compound 16f (52% reduction in the cell viability at 10 µM, p < 
0.001) (Figure-4).  
   






























































































































    
     
    
Figure 3. Neuroprotective effects of (A) Compound-1d, (B) Compound-4d, (C) Compound-12d, (D) Compound-12f, (E) 
Compound-14d, (F) Compound-14f, (G) Compound-16d, (H) Compound-16f, (I) Compound-18d, and (J) Compound-18f in a 
dose dependent manner in the concentration range 0.1-3 µM against H2O2-induced oxidative stress in SH-SY5Y cells. Cells 
without treatment serve as control. Data are expressed as the mean ± standard error of the mean (SEM) (n = 3). Statistical 
significance was estimated by one-way ANOVA followed by Bonferroni’s post hoc test, (#)-significance with respect to the 






























































































































































































Figure 4. Toxic effects of compounds 1d, 4d, 12d, 12f, 14d, 14f, 16d, 16f, 18d and 18f evaluated at 3 and 10 µM 
concentrations against SH-SY5Y cells. Cells without treatment serve as control. Data are expressed as the mean ± standard 
error of the mean (SEM) (n = 3). Statistical significance was estimated with respect to the control by one-way ANOVA, 
followed by Bonferroni’s post hoc test (***p < 0.001). 
Taken together, the neuroprotective evaluation of these compounds (1c-f to 19c-f) indicates that both 
the number and positions of the hydroxyl groups affects the neuroprotective abilities of flavones. Our 
results, in line with previous data [34], also highlight that the catecholic hydroxy substitution is 
indispensable for the neuroprotective activity. Systematic comparison of hydroxy flavones and 
methoxy flavones has also shown that the complete methylation of hydroxy groups renders the 
flavones inactive, hence, free hydroxyls are considered crucial for the neuroprotective activity. 
Therefore, one significant, novel contribution of this study is the demonstration that the B-ring phenyl 
group is important for neuroprotective activity. Moreover, a significant loss of neuroprotective activity 
of flavones, as observed with the bioisosteric replacement of the B-ring phenyl group, strongly 
suggests that π interactions of this phenyl ring play a key role in the neuroprotective activity. Also, in 
this study, the differential effects of 7,8-dihydroxy flavones (with 4-C=O) and 7,8-dihydroxy 4-
thioflavones (with 4-C=S) and the substitution of EWGs have been shown. The correlation between the 































































































































































C=O with 4-C=S and the substitution of EWGs are beneficial for neuroprotection, which is most likely to 
be a consequence of the increased hydrophobicity [34,35]. 
Molecular mechanism of action: Flavones can act either as a free radical scavenger (antioxidant) or by 
triggering intracellular pathways for cell survival. Therefore, to gain insight into the molecular 
mechanism of action underlying the neuroprotective activities of these flavones, their antioxidant 
potentials and impact on certain intracellular signalling targets were explored.  
Antioxidant activity: Flavones are very well known for their antioxidant activities [2,36], therefore the 
antioxidant properties of flavones 1d (7,8-dihydroxy flavone), 4d (luteolin, a well-known natural 
flavone) and compound-14d with a 4-C=O moiety, as well as the neuroprotective 4-thioflavones (with 
4-C=S) 14f, 16f and 18f were studied. For this, the flavones were evaluated at their neuroprotective 
concentration of 3 M both for their ability to directly interact with free radicals (primary antioxidant 
activity) using a DPPH free radical scavenging assay and for their ability to bind to ferrous (Fe2+) ion 
that catalyses oxidation (secondary antioxidant activity), using a metal chelating assay (Table-1).  As 
shown in Table 1, all the aforementioned flavones showed very low scavenging activity (only up to 
1.9% inhibition of DPPH radical) at 3 M, at which neuroprotection by these flavones was observed. 
Also, based on previous reports on DPPH scavenging data for the well-known flavones (1d and 4d, 
Series-1), no correlation was found between the order of their neuroprotective abilities [1d (Cell 
viability-97%) > 4d (Cell viability-73%, p < 0.05)] and the order of their scavenging activity [DPPH 
radical scavenging activity- IC50-4d (11.04 ± 0.38 µM) > 1d (15.50 ± 0.12 µM)] [37]. Since, in general, 
compounds with catechol groups are defined as effective metal chelators [38–40], the iron-chelating 
ability of flavones 1d, 4d, 14d, 14f, 16f and 18f at 3 µM was further studied. Interestingly, a low degree 
of Fe2+ chelation (only up to 5%) was exhibited by these flavones at 3 M concentration (Table 1).  
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Taken together, it can be concluded that these flavones possess weaker antioxidant activity at their 
tested concentration, and hence antioxidant activity alone may not be sufficient to explain their 
observed neuroprotective effects. Therefore, to further probe the molecular mechanism of these 
flavones their affects on intracellular signalling pathways were explored. 
Table 1. Antioxidant activities of flavones 
Flavones 
Antioxidant activity at 3 µM concentration
a 
 
DPPH scavenging assay 
(Scavenging activity, %) 
Metal chelating assay 
(Fe
2+
 chelating activity, %) 
1d 1.4  0.2 3.7  1.0 
4d 1.9  0.2 3.4  0.4 
14d 1.4  0.5 3.7  1.2 
14f 1.7  0.2 5.0  1.6 
16f 1.6  0.6 4.4  1.7 
18f 1.3  0.2 3.9  0.4 
Ascorbic acid
b
 1.3  0.5 - 
EDTA
c
 - 6.9  0.4 
a 
Data expressed as Mean ± SEM, n = 3; 
b
Ascorbic acid was used as a reference standard for the DPPH scavenging assay, IC50 
value of ascorbic acid for the inhibition of DPPH radical formation was established to be 330  0.5 µM (Supplementary info, 
Figure-S2); 
c
EDTA was used as a reference standard for the metal chelating assay, IC50 value of EDTA in metal chelating 
assay was determined to be 42  0.8 µM (Supplementary info, Figure-S3).  
Intracellular signalling: Accumulative evidence has shown that flavonoids display signalling properties 
during neuroprotection [17,41,42] [43] [44,45]. Hence, we explored the potential intracellular targets 
involved in the neuroprotective function of flavones. For this, the signal mediated in SH-SY5Y cells by 
the well-known compounds 1d, 4d (luteolin) and compound-14d with a 4-C=O moiety, as well as the 
neuroprotective 4-thioflavones (with 4-C=S) 14f, 16f and 18f, were studied. Pooled samples from three 
independent treatments of SH-SY5Y cells with and without H2O2 (130 µM), and with these compounds 
at 3 µM concentration for 24 h followed by the exposure to H2O2 (1 h) [42], were analysed using the 
PathScan® Intracellular Signalling Array Kit (Figure-5). These compounds were found to modulate the 
signalling molecules that are associated with cellular survival and apoptosis such as ERK1/2, mTOR, 
AMPKα and Akt targets such as Bad and PRAS40. Treatment of SH-SY5Y cells with H2O2 (130 µM) 
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resulted in a marked reduction in phosphorylation of ERK1/2, mTOR, Bad and PRAS40. Pre-treatment 
with 7,8-dihydroxy flavones (containing 4-C=O) showed that compounds 1d and 4d were able to confer 
neuroprotection by the inhibition of apoptosis through restoration of Bad (a pro-apoptotic protein) 
phosphorylation (by inactivating its apoptotic activity), whereas, compound 14d was shown to elicit its 
activity through restoration of mTOR phosphorylation, which restores protein synthesis. In the case of 
4-thioflavones, compound 14f significantly restored phosphorylation of ERK1/2, mTOR, Bad and 
PRAS40 up to the same levels or higher than that observed in the control, along with activation of 
AMPKα. Also, compound 18f was found to restore phosphorylation of ERK1/2 and mTOR, along with 
activation of AMPKα, however, compound 16f showed restoration of Bad phosphorylation only. These 
results support the in vitro observations and suggest that the neuroprotective effects of flavones are 
mediated via ERK1/2 and PI3K/Akt/mTOR pathways and that these flavones differentially activate the 
pro-survival protein kinases based on their chemical structure. Also, a comparison of intracellular 
signalling of the 4-thioflavone 14f with its corresponding flavone 14d highlights the positive influence 
of the 4-C=S substitution on the neuroprotective activity. Indeed, the enhanced neuroprotective 
effects of compounds 14f and 18f can be attributed to their potential to modulate multiple signalling 
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Figure 5. (A) Chemiluminescent array images of the PathScan Intracellular Signalling array kit revealing various 
phosphorylated in SH-SY5Ycells pre-treated with and without compounds 1d, 4d, 14d, 14f, 16f and 18f at 3 µM for 24 h 
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the integrated density of phosphorylated signalling nodes in the array image of SH-SY5Ycells pre-treated with and without 
compounds 1d, 4d, 14d, 14f, 16f and 18f at 3 µM for 24h before exposure to H2O2 (130 µM). Data are expressed as the 
mean ± standard error of the mean (SEM) (n = 4). Statistical significance was estimated with respect to the control (#) and 
with respect to H2O2 (*) by one-way ANOVA, followed by Bonferroni’s post hoc test (ns-not significant, *p < 0.05, **p < 
0.01, ***p < 0.001 and ****p < 0.001). (C) Molecular mechanism of action of 1d, 4d, 14d, 14f, 16f and 18f in SH-SY5Y cell 
line. 
Correlation between neuroprotective activity and BBB permeability : This correlation was probed by 
plotting the neuroprotective ability of each of the flavones against its predicted BBB score (Figure-6). 
This showed that the novel compounds 14f and 18f possess both high neuroprotective ability (cell 
viability > 95%, neuroprotective even at 0.3 µM concentration) and high BBB permeability (BBB score > 
0.02). In contrast, the natural/well-known flavones such as 7,8-dihydroxy flavone (1d), luteolin (4d) 
and quercetin (5d) were found to be neuroprotective with poor BBB permeability. Therefore, the novel 






Figure 6. Graph represents BBB permeability of compounds (predicted BBB score) versus neuroprotective activity (cell 
viability) determined at 3µm using the SH-SY5Y neuroblastoma cell line. The dashed line at x = 0.02 represents the 
threshold BBB-/BBB+ score and the dashed line at y = 50 represents 50% cell viability in SH-SY5Y cells exposed to H2O2.  
Neuroprotective natural flavone/well-known flavones are highlighted in blue and the thioflavones that have been identified 
to be neuroprotective are highlighted in red. Lower left quadrant represents low neuroprotective activity and no BBB 
permeability, lower right quadrant represents low neuroprotective activity and high BBB permeability, upper left quadrant 
represents high neuroprotective activity and no BBB permeability and upper right quadrant represents high 
neuroprotective activity and high BBB permeability. 
 
CONCLUSIONS 
In summary, evaluation of the neuroprotective properties of structurally related methoxy flavones, 
hydroxy flavones and their 4-thio analogues has provided significant insights into the SARs of flavones, 




Figure 7. Summary of the SARs on the neuroprotective activities of flavones. 
 In particular, the presence of catecholic hydroxyl groups on ring-A, and the presence of the B-ring 
phenyl group, were found to be essential for neuroprotection. In addition, the presence of EWGs at C4’ 
of the B-ring phenyl, as well as 4-C=S substitution, were found to be beneficial for neuroprotection. In 
general, 7,8-dihydroxy 4-thioflavones such as compounds 14f and 18f were found to exhibit potent 
neuroprotective effects against H2O2-induced oxidative stress with their activity being restored even at 
0.3 µM concentration. Investigation of the molecular mechanism of action of key leads indicated that 
these compounds preferably mediate their neuroprotective effects through suppression of apoptosis 
by activating the anti-apoptotic proteins, and inactivating the pro-apoptotic proteins of the ERK1/2 
and PI3K/Akt/mTOR pathways. Overall, the neuroprotective compounds identified in this study 




Increased levels of oxidative stress are closed linked with many neurodegenerative diseases such 
as Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis [46–48]. Hence, 




neuroprotection against oxidative stress are of significant importance for developing effective 
treatment for these neurodegenerative diseases [14,49]. In this context, identification of novel 
neuroprotective agents with favourable pharmacokinetic profiles and CNS distribution is of pivotal 
importance. Therefore, the novel flavones 14f and 18f, with potential neuroprotective activities, along 
with favourable BBB permeability, can be considered as promising candidates for further optimisation 
and development as neuroprotective agents. In this regard, future studies that will decipher the 
pharmacokinetic and pharmacodynamic properties of these novel compounds will further guide the 
optimisation of these candidates for neuroprotective applications.  
EXCECUTIVE SUMMARY 
• A library of 76 structurally related flavones have been screened for their neuroprotective activities 
against H2O2-induced oxidative stress.  
 • Substitution of 4-C=S and EWGs at C4’ of the B-ring phenyl resulted in compounds with enhanced 
neuroprotective properties.  
• Further structural optimisation of the identified novel lead candidates, and in vivo evaluation, are 
required to develop novel neuroprotective agents. 
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ABBREVIATIONS 
MTT-3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, DPPH-2,2-diphenyl-1-
picrylhydrazyl, EDTA-Ethylenediaminetetraacetic acid, ERK1/2-extracellular signal-regulated kinase, 
mTOR-mammalian target of rapamycin, AMPKα-5' adenosine monophosphate-activated protein 
kinase, GSK-3β- Glycogen synthase kinase-3β, Bad-Bcl-2-associated death promoter, PRAS40-proline-
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